Dabigatran recalls: lots, NDC and companies
3 FDA recall records mention Dabigatran since December 18, 2024. Each covers specific lots from one company. Check yours below.
Check your Dabigatran bottle
Hazard and remedy text is quoted from the agency, unedited. The tag names the kind of risk with a word from that text. Every notice links to its official page.
Ascend Laboratories, LLC: Dabigatran Etexilate Capsules and 2 more
Hazard (FDA): Failed impurity/degradation specification: an OOS result observed in Related substance test analysis w.r.t Impurity II, Impurity III and Total impurities for 12-month stability
FDAMedicines
Ascend Laboratories, LLC: Dabigatran etexilate Capsules and 1 more
Hazard (FDA): Failed Impurities/Degradation Specifications: OOS result was observed during the related substance test analysis with respect to Impurity II, Impurity III and Total impurity testing for 12 Month Long-Term Stability.
FDAMedicines
Ascend Laboratories, LLC: Dabigatran Etexilate and 1 more
Hazard (FDA): CGMP Deviations: Presence of N-nitroso-Dabigatran impurity above recommended interim limit
FDAMedicines